Group One Trading
NAUT icon

Group One Trading’s Nautilus Biotechnolgy NAUT Stock Holding History

Group One Trading’s Portfolio NAUT Stock Details NAUT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$388 Buy
+100
New +$246 ﹤0.01% 7342
2024
Q1 		– Sell
-12,500
Closed -$37.4K – 7655
2023
Q4 		$37.4K Sell
12,500
-1,000
-7% -$2.86K ﹤0.01% 5295
2023
Q3 		$42.7K Buy
+13,500
New +$43.9K ﹤0.01% 5252
2023
Q1 		– Sell
-1,500
Closed -$2.7K – 7679
2022
Q4 		$2.7K Sell
1,500
-500
-25% -$965 ﹤0.01% 6555
2022
Q3 		$4K Sell
2,000
-1,600
-44% -$4.02K ﹤0.01% 6939
2022
Q2 		$10K Sell
3,600
-72,800
-95% -$271K ﹤0.01% 6761
2022
Q1 		$332K Sell
76,400
-222,000
-74% -$911K ﹤0.01% 4261
2021
Q4 		$1.55M Buy
298,400
+204,000
+216% +$1.09M ﹤0.01% 2879
2021
Q3 		$580K Buy
+94,400
New +$752K ﹤0.01% 4024

Other funds holding NAUT

ACM
AH Capital Management Menlo Park, California $1.29B AUM 26.81% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
CM
Cercano Management Bellevue, Washington $2.32B AUM 30.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CA
Clearstead Advisors Cleveland, Ohio $10.9B AUM 18.41% 1-Year Est. Return
CFM
Comprehensive Financial Management Los Gatos, California $3.01B AUM 2.93% 1-Year Est. Return
ACI
Amazon.com Inc Seattle, Washington $2.63B AUM 20.53% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
ST
Sentinel Trust Houston, Texas $1.13B AUM 24.31% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Group One Trading's NAUT Position: Q1 2026 in Review

Group One Trading sold out of Nautilus Biotechnolgy (NAUT) in Q1 2026, closing a stake of 3,880 shares — an estimated $9.53K sold.

Group One Trading first reported a position in NAUT in Q3 2021 and held it in 5 quarters. The position peaked at $415K in Q1 2023. 81 funds tracked by Wall St. Rank hold NAUT as of Q1 2026.

  • Group One Trading reported no remaining Nautilus Biotechnolgy position as of Q1 2026 after selling out during the quarter.
  • Group One Trading sold 3,880 Nautilus Biotechnolgy shares in Q1 2026, an estimated $9.53K.
  • Group One Trading first reported a position in Nautilus Biotechnolgy in Q3 2021 and held it in 5 quarters.
  • Group One Trading's Nautilus Biotechnolgy position peaked at $415K in Q1 2023.
  • 81 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.